Definition, Incidence, Correlates, and Clinical Impact of “Nuisance” Bleeding in Patients Undergoing Drug-Eluting Stent Implantation
- 7 September 2009
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 104 (5), 30C-33C
- https://doi.org/10.1016/j.amjcard.2009.06.012
Abstract
No abstract availableKeywords
Funding Information
- Schering-Plough
- Medicines Company
- GlaxoSmithKline
- Sanofi
This publication has 15 references indexed in Scilit:
- Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?The American Journal of Cardiology, 2009
- Assessment of Bleeding Events in Clinical Trials—Proposal of a New ClassificationThe American Journal of Cardiology, 2007
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent PlacementCirculation, 2006
- Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery diseaseEuropean Heart Journal, 2006
- Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 TrialCirculation, 2005
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary SyndromesCirculation, 2003
- Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary InterventionJAMA, 2002
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinaseJournal of the American College of Cardiology, 1988